Enlivex Therapeutics Ltd
ENLV1.660USD
+0.210+14.48%
시장 운영 시간 （ET）시세는 15분 지연됩니다
39.59M시가총액
손실P/E TTM
자세한 내용은 Enlivex Therapeutics Ltd 회사
Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.
회사 정보
종목 코드 ENLV
회사 이름Enlivex Therapeutics Ltd
상장일Jul 30, 2014
CEODr. Oren Hershkovitz, Ph.D.
직원 수36
유형Ordinary Share
회계 연도 종료Jul 30
주소14 Einstein St.
도시NESS-ZIONA
증권 거래소NASDAQ Capital Market Consolidated
국가Israel
우편 번호7403618
전화97286623301
웹사이트https://www.enlivex.com/
종목 코드 ENLV
상장일Jul 30, 2014
CEODr. Oren Hershkovitz, Ph.D.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Shai A. Novik
Mr. Shai A. Novik
Executive Chairman of the Board
Executive Chairman of the Board
858.77K
+10.95%
Prof. Dror Mevorach, M.D.
Prof. Dror Mevorach, M.D.
Founder, Chief Scientific Officer and Medical Officer
Founder, Chief Scientific Officer and Medical Officer
242.34K
+3.28%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
181.46K
+1.07%
Mrs. Shachar Shlosberger, CPA
Mrs. Shachar Shlosberger, CPA
Chief Financial Officer
Chief Financial Officer
6.41K
+241.84%
Dr. Gili Hart, Ph.D.
Dr. Gili Hart, Ph.D.
Independent Director
Independent Director
5.29K
+56.84%
Dr. Brian Schwartz, M.D.
Dr. Brian Schwartz, M.D.
Director
Director
1.83K
+100.00%
Dr. Bernhard Jurgen Kirschbaum, Ph.D.
Dr. Bernhard Jurgen Kirschbaum, Ph.D.
Director
Director
--
--
Dr. Oren Hershkovitz, Ph.D.
Dr. Oren Hershkovitz, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Baruch Halpert
Mr. Baruch Halpert
Director
Director
--
--
Sangwoo Lee
Sangwoo Lee
Director
Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Shai A. Novik
Mr. Shai A. Novik
Executive Chairman of the Board
Executive Chairman of the Board
858.77K
+10.95%
Prof. Dror Mevorach, M.D.
Prof. Dror Mevorach, M.D.
Founder, Chief Scientific Officer and Medical Officer
Founder, Chief Scientific Officer and Medical Officer
242.34K
+3.28%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
181.46K
+1.07%
Mrs. Shachar Shlosberger, CPA
Mrs. Shachar Shlosberger, CPA
Chief Financial Officer
Chief Financial Officer
6.41K
+241.84%
Dr. Gili Hart, Ph.D.
Dr. Gili Hart, Ph.D.
Independent Director
Independent Director
5.29K
+56.84%
Dr. Brian Schwartz, M.D.
Dr. Brian Schwartz, M.D.
Director
Director
1.83K
+100.00%
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Fri, May 23
마지막 업데이트: Fri, May 23
주주
주주 유형
주주
주주
비율
Armistice Capital LLC
7.47%
Novik (Shai A)
3.60%
Millennium Management LLC
2.81%
Morgan Stanley Smith Barney LLC
0.96%
Havron (Abraham)
0.76%
Other
84.40%
주주
주주
비율
Armistice Capital LLC
7.47%
Novik (Shai A)
3.60%
Millennium Management LLC
2.81%
Morgan Stanley Smith Barney LLC
0.96%
Havron (Abraham)
0.76%
Other
84.40%
주주 유형
주주
비율
Hedge Fund
11.45%
Individual Investor
4.61%
Investment Advisor
1.41%
Research Firm
0.47%
Investment Advisor/Hedge Fund
0.10%
Other
81.96%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
48
4.30M
18.04%
-270.43K
2025Q1
51
5.97M
25.02%
-258.45K
2024Q4
49
6.10M
27.74%
+737.29K
2024Q3
43
5.25M
23.90%
+285.76K
2024Q2
47
4.79M
22.40%
+1.35M
2024Q1
46
3.03M
14.05%
-328.65K
2023Q4
48
2.85M
15.31%
-503.64K
2023Q3
50
3.93M
21.15%
-597.01K
2023Q2
52
3.97M
21.39%
-603.59K
2023Q1
56
4.01M
21.61%
-571.54K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Armistice Capital LLC
1.78M
7.47%
-426.07K
-19.30%
Mar 31, 2025
Novik (Shai A)
858.77K
3.6%
+84.74K
+10.95%
Mar 31, 2025
Millennium Management LLC
669.01K
2.81%
+35.16K
+5.55%
Mar 31, 2025
Morgan Stanley Smith Barney LLC
229.73K
0.96%
-38.97K
-14.50%
Mar 31, 2025
Havron (Abraham)
181.46K
0.76%
+1.92K
+1.07%
Mar 31, 2025
Renaissance Technologies LLC
181.29K
0.76%
+22.30K
+14.02%
Mar 31, 2025
Jane Street Capital, L.L.C.
80.76K
0.34%
+67.89K
+527.35%
Mar 31, 2025
Citadel Advisors LLC
70.14K
0.29%
+70.14K
--
Mar 31, 2025
Hershkovitz (Oren Ph.D.)
42.05K
0.18%
+16.55K
+64.92%
Mar 31, 2025
ESALIENS TFI SA
40.00K
0.17%
--
--
Dec 31, 2023
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
